Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients.
about
ARID2: a new tumor suppressor gene in hepatocellular carcinomaIdentification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray dataDetection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma.Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospectsMolecular genetics of hepatocellular neoplasia.Cell cycle biology of fibrolamellar hepatocellular carcinomaThe genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients.Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach.Natural history of hepatitis-related hepatocellular carcinoma.Detection of chromosomal imbalances in hepatocellular carcinoma.Genomic analysis of fibrolamellar hepatocellular carcinoma.Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects.Update on the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus InfectionPredominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17.Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach.Fibrolamellar carcinoma: 2012 updateMethylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3.Fibrolamellar hepatocellular carcinoma.Hepatocellular carcinoma: the point of view of the hepatitis B virus.Role of hepatitis B virus DNA integration in human hepatocarcinogenesis.Liver cell transformation in chronic HBV infection.Insertion/deletion polymorphisms are convenient and reliable markers to assess chromosomal instability in human tumors.Specific association between alcohol intake, high grade of differentiation and 4q34-q35 deletions in hepatocellular carcinomas identified by high resolution allelotyping.Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation.Managing patients receiving sorafenib for advanced hepatocellular carcinoma: a case study.Epigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas.HBxAPα/Rsf-1-mediated HBx-hBubR1 interactions regulate the mitotic spindle checkpoint and chromosome instability.Regional over-representations on chromosomes 1q, 3q and 7q in the progression of hepatitis B virus-related hepatocellular carcinoma.Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma.Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors.Hepatocellular carcinomaChromosomal analysis of hepatic adenoma and focal nodular hyperplasia by comparative genomic hybridization
P2860
Q24607045-BDEC0388-B37D-45C3-B61C-8425222D6CEEQ24803258-C7E6BD4F-2218-4E79-BA6D-94AAD04CA08BQ27852915-3AB22DE9-D765-40CA-9D93-085A6D6BFED6Q33652971-2F5255CA-81C1-4FB3-9CC2-CE96BE1D03DDQ33661037-48000CA7-C960-45AD-9003-A9A387E8A3FEQ33680701-FECA061A-B833-482C-945A-168136E5094CQ34357930-793FCD7D-204E-47B2-ACB0-BF97C19ADE9EQ34458870-F61BB3B8-05C7-47ED-9B67-C358577C2626Q34510171-87128832-5EA6-46EF-8AB2-675B26FB4964Q34589546-52E1FEB2-8676-46F5-99C3-442E817731EBQ34606310-C48754FB-ED46-4739-878F-D78DF130F6ECQ34673400-82BDD5A3-A3B3-4F8B-A782-B2F5751F3E32Q34850055-BA2607B6-8140-49D6-863D-AF37D5F4BBEBQ34892826-C4BFDF8F-8466-4BAB-AD10-95CC54D2C599Q37175500-4C51BA27-6214-49F2-9321-308B18B648A9Q37285249-2F826780-D946-48EF-8822-344085198433Q37288706-CEC3F636-0513-4578-AEFE-C17D7C41EE6EQ37295572-63DC02D2-0D43-412F-AAB6-C8B1D75AA0FEQ37565016-1C1D6D74-5FEA-40EE-B759-490E88C3A5C9Q37888329-89A3F8CC-7851-447C-B6DE-E6280A378BB3Q38216013-195A6A22-E611-4AA8-B760-575214B7FE10Q38613586-DF56BAF3-2A9C-4867-8066-C30861C7AC33Q39609298-3D871D7D-A71D-46A0-AB4A-AE76597CD8BEQ40750117-662690D1-D981-43F5-B1F7-8FA6EBC00F03Q42131254-BDC10EED-961C-435E-A587-45F67C4BFE79Q42948849-70CD6F3F-E6F2-4EB9-97B0-92DAB34EAB87Q43492270-D20DF371-F5FE-45D3-9387-C8977C420305Q43529384-EC40260E-8EEE-413A-B749-4ADBBED8B910Q45534049-D363E250-3005-4432-893D-2CA76FF898FFQ53315041-108127C0-094D-48E5-9CD2-E4EC42A1F6A8Q53391613-92CAA687-A3DA-4833-8484-C700867768E6Q56907503-9FF5412C-2135-40C5-8FD9-4BD3E1AF28C9Q58814564-DB56CEA7-40C2-4FBC-A4AD-25DCF9CAB900
P2860
Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Distinct chromosomal abnormali ...... ncer of non-B, non-C patients.
@en
Distinct chromosomal abnormali ...... ncer of non-B, non-C patients.
@nl
type
label
Distinct chromosomal abnormali ...... ncer of non-B, non-C patients.
@en
Distinct chromosomal abnormali ...... ncer of non-B, non-C patients.
@nl
prefLabel
Distinct chromosomal abnormali ...... ncer of non-B, non-C patients.
@en
Distinct chromosomal abnormali ...... ncer of non-B, non-C patients.
@nl
P2093
P2860
P356
P1433
P1476
Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1203713
P407
P577
2000-08-01T00:00:00Z